InsiderTrades

Form 4 for OPRX OptimizeRx Corp

Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0001628280-25-058412 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-22 2025-12-19 OPRX Silvestro Stephen L CEO M - OptEx $0.00 +6,546 195.5K +3% $0
D 2025-12-22 2025-12-19 OPRX Silvestro Stephen L CEO F - Tax $13.51 -1,594 193.9K -0.8% -$21.5K
D 2025-12-22 2025-12-19 OPRX Silvestro Stephen L CEO M - OptEx $0.00 -6,546 6,547 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-19 M A 6,546 $0.00 195,462 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2025-12-19 F D 1,594 $13.51 193,868 D — — (F2) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
3 Derivative Restricted Stock Units 2025-12-19 M D 6,546 $0.00 6,547 D — · — to 2026-12-19 6,546 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.